172 related articles for article (PubMed ID: 15623318)
1. WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model.
Mazor O; Brandis A; Plaks V; Neumark E; Rosenbach-Belkin V; Salomon Y; Scherz A
Photochem Photobiol; 2005; 81(2):342-51. PubMed ID: 15623318
[TBL] [Abstract][Full Text] [Related]
2. WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice.
Neuschmelting V; Kim K; Malekzadeh-Najafabadi J; Jebiwott S; Prakash J; Scherz A; Coleman JA; Kircher MF; Ntziachristos V
Theranostics; 2018; 8(3):723-734. PubMed ID: 29344301
[No Abstract] [Full Text] [Related]
3. Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins.
Brandis A; Mazor O; Neumark E; Rosenbach-Belkin V; Salomon Y; Scherz A
Photochem Photobiol; 2005; 81(4):983-93. PubMed ID: 15839743
[TBL] [Abstract][Full Text] [Related]
4. Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine.
Murray KS; Winter AG; Corradi RB; LaRosa S; Jebiwott S; Somma A; Takaki H; Srimathveeravalli G; Lepherd M; Monette S; Kim K; Scherz A; Coleman JA
J Urol; 2016 Jul; 196(1):236-43. PubMed ID: 26860792
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.
Chevalier S; Cury FL; Scarlata E; El-Zayat E; Hamel L; Rocha J; Zouanat FZ; Moussa S; Scherz A; Elhilali M; Anidjar M
J Urol; 2013 Nov; 190(5):1946-53. PubMed ID: 23680311
[TBL] [Abstract][Full Text] [Related]
6. Serine conjugates of chlorophyll and bacteriochlorophyll: photocytotoxicity in vitro and tissue distribution in mice bearing melanoma tumors.
Rosenbach-Belkin V; Chen L; Fiedor L; Tregub I; Paviotsky F; Brumfeld V; Salomon Y; Scherz A
Photochem Photobiol; 1996 Jul; 64(1):174-81. PubMed ID: 8787011
[TBL] [Abstract][Full Text] [Related]
7. Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy.
Moore CM; Azzouzi AR; Barret E; Villers A; Muir GH; Barber NJ; Bott S; Trachtenberg J; Arumainayagam N; Gaillac B; Allen C; Schertz A; Emberton M
BJU Int; 2015 Dec; 116(6):888-96. PubMed ID: 24841929
[TBL] [Abstract][Full Text] [Related]
8. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
Fabre MA; Fuseau E; Ficheux H
J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
[TBL] [Abstract][Full Text] [Related]
9. Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.
Chevalier S; Anidjar M; Scarlata E; Hamel L; Scherz A; Ficheux H; Borenstein N; Fiette L; Elhilali M
J Urol; 2011 Jul; 186(1):302-9. PubMed ID: 21600602
[TBL] [Abstract][Full Text] [Related]
10. Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate.
Fleshker S; Preise D; Kalchenko V; Scherz A; Salomon Y
Photochem Photobiol; 2008; 84(5):1231-7. PubMed ID: 18399928
[TBL] [Abstract][Full Text] [Related]
11. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity.
Preise D; Oren R; Glinert I; Kalchenko V; Jung S; Scherz A; Salomon Y
Cancer Immunol Immunother; 2009 Jan; 58(1):71-84. PubMed ID: 18488222
[TBL] [Abstract][Full Text] [Related]
12. Antivascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy.
Zilberstein J; Schreiber S; Bloemers MC; Bendel P; Neeman M; Schechtman E; Kohen F; Scherz A; Salomon Y
Photochem Photobiol; 2001 Mar; 73(3):257-66. PubMed ID: 11281022
[TBL] [Abstract][Full Text] [Related]
13. Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin.
Ashur I; Goldschmidt R; Pinkas I; Salomon Y; Szewczyk G; Sarna T; Scherz A
J Phys Chem A; 2009 Jul; 113(28):8027-37. PubMed ID: 19545111
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of localized prostate cancer by vascular-targeted photodynamic therapy with WST11].
Lebdai S; Martin F; Bigot P; Azzouzi AR
Prog Urol; 2014 Nov; 24(14):911-4. PubMed ID: 25195031
[TBL] [Abstract][Full Text] [Related]
15. Light-dependent oxygen consumption in bacteriochlorophyll-serine-treated melanoma tumors: on-line determination using a tissue-inserted oxygen microsensor.
Zilberstein J; Bromberg A; Frantz A; Rosenbach-Belkin V; Kritzmann A; Pfefermann R; Salomon Y; Scherz A
Photochem Photobiol; 1997 Jun; 65(6):1012-9. PubMed ID: 9188281
[TBL] [Abstract][Full Text] [Related]
16. Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy.
Kim K; Zhang H; La Rosa S; Jebiwott S; Desai P; Kimm S; Scherz A; O'Donoghue JA; Weber WA; Coleman JA
Clin Cancer Res; 2017 Jul; 23(13):3343-3351. PubMed ID: 28108545
[No Abstract] [Full Text] [Related]
17. Biodistribution and photodynamic efficacy of a water-soluble, stable, halogenated bacteriochlorin against melanoma.
Dąbrowski JM; Urbanska K; Arnaut LG; Pereira MM; Abreu AR; Simões S; Stochel G
ChemMedChem; 2011 Mar; 6(3):465-75. PubMed ID: 21265022
[TBL] [Abstract][Full Text] [Related]
18. Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin.
Dąbrowski JM; Krzykawska M; Arnaut LG; Pereira MM; Monteiro CJ; Simões S; Urbańska K; Stochel G
ChemMedChem; 2011 Sep; 6(9):1715-26. PubMed ID: 21732537
[TBL] [Abstract][Full Text] [Related]
19. Homologous adaptation to oxidative stress induced by the photosensitized Pd-bacteriochlorophyll derivative (WST11) in cultured endothelial cells.
Plaks V; Posen Y; Mazor O; Brandis A; Scherz A; Salomon Y
J Biol Chem; 2004 Oct; 279(44):45713-20. PubMed ID: 15339936
[TBL] [Abstract][Full Text] [Related]
20. Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.
Taneja SS; Bennett J; Coleman J; Grubb R; Andriole G; Reiter RE; Marks L; Azzouzi AR; Emberton M
J Urol; 2016 Oct; 196(4):1096-104. PubMed ID: 27291652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
